Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Tactile Systems Technology
TCMD
$548M
| $5.67M | 0.01% |
198,300
+51,100
| +35% | +$1.15M |
|
1627
Graham Corp
GHM
$1.34B
| $5.67M | 0.01% |
288,200
+53,000
| +23% | +$1.13M |
|
|
GOGL
1628
DELISTED
Golden Ocean Group
GOGL
| $5.65M | 0.01% |
841,372
-347,738
| -29% | -$2.37M |
|
|
VLP
1629
DELISTED
Valero Energy Partners LP
VLP
| $5.64M | 0.01% |
123,609
+10,131
| +9% | +$466K |
|
1630
RadNet
RDNT
$6.01B
| $5.64M | 0.01% |
727,400
+219,900
| +43% | +$1.5M |
|
1631
Littelfuse
LFUS
$11.6B
| $5.63M | 0.01% |
+34,092
| New | +$5.48M |
|
|
XENT
1632
DELISTED
Intersect ENT, Inc
XENT
| $5.62M | 0.01% |
+201,000
| New | +$4.55M |
|
1633
Gray Television
GTN
$538M
| $5.61M | 0.01% |
409,150
-368,200
| -47% | -$4.97M |
|
|
PIR
1634
DELISTED
Pier 1 Imports, Inc.
PIR
| $5.61M | 0.01% |
54,000
-3,579
| -6% | -$432K |
|
1635
West Bancorporation
WTBA
$508M
| $5.6M | 0.01% |
236,800
-22,900
| -9% | -$527K |
|
|
FNFV
1636
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $5.56M | 0.01% |
351,700
+168,100
| +92% | +$2.33M |
|
1637
First Solar
FSLR
$24.2B
| $5.55M | 0.01% |
+139,300
| New | +$4.73M |
|
1638
Transportadora de Gas del Sur
TGS
$4.23B
| $5.55M | 0.01% |
347,166
-51,694
| -13% | -$780K |
|
|
MODN
1639
DELISTED
MODEL N, INC.
MODN
| $5.54M | 0.01% |
416,184
+42,984
| +12% | +$514K |
|
1640
BOK Financial
BOKF
$8.88B
| $5.53M | 0.01% |
65,745
-18,397
| -22% | -$1.5M |
|
|
ITG
1641
DELISTED
Investment Technology Group Inc
ITG
| $5.53M | 0.01% |
260,300
+149,500
| +135% | +$3.05M |
|
|
CA
1642
DELISTED
CA, Inc.
CA
| $5.51M | 0.01% |
+160,000
| New | +$5.18M |
|
1643
York Water
YORW
$541M
| $5.51M | 0.01% |
158,200
+200
| +0.1% | +$7.04K |
|
|
MN
1644
DELISTED
MANNING & NAPIER, INC.
MN
| $5.5M | 0.01% |
1,265,600
+185,000
| +17% | +$919K |
|
|
LEAF
1645
DELISTED
Leaf Group Ltd.
LEAF
| $5.49M | 0.01% |
704,400
-11,600
| -2% | -$93.9K |
|
1646
UFP Industries
UFPI
$4.96B
| $5.47M | 0.01% |
188,109
+152,700
| +431% | +$4.64M |
|
1647
German American Bancorp
GABC
$1.93B
| $5.47M | 0.01% |
160,550
+8,000
| +5% | +$256K |
|
|
STFC
1648
DELISTED
State Auto Financial Corp
STFC
| $5.45M | 0.01% |
211,800
+21,700
| +11% | +$558K |
|
|
TGB
1649
Trekor Metals
TGB
$3.06B
| $5.45M | 0.01% |
4,287,500
-67,100
| -2% | -$81.2K |
|
1650
Unifirst Corp
UNF
$5.19B
| $5.45M | 0.01% |
38,700
+4,100
| +12% | +$571K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.